首页 › 基金 › Rangeley Capital, LLC › KROS
Rangeley Capital, LLC 对 KROS 的持仓历史
KEROS THERAPEUTICS INC · 医疗保健
Rangeley Capital, LLC 在 Q2 2026 的 13F 申报中披露持有 KROS(KEROS THERAPEUTICS INC)54,400 股,市值约 US$582K,约占其申报组合的 0.55%,在其申报持仓中市值排名第 47 位。 Rangeley Capital, LLC 最近 6 个申报季度中有 6 个季度披露了 KROS 持仓,最早可追溯至 Q1 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Rangeley Capital, LLC 对 KROS 的持仓演变
Rangeley Capital, LLC 于 Q1 2025 首次披露 KROS 持仓:408,234 股(约 US$4.2M)。 在 6 次申报中,Rangeley Capital, LLC 0 次增持、4 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 54,400 股、市值约 US$582K。 持仓曾出现大幅变动:Q2 2025 减持约 30% (随后一个季度股价上涨 19%)、Q4 2025 减持约 63% (随后一个季度股价下跌 46%)、Q1 2026 减持约 44% (随后一个季度股价下跌 3%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2025 | 408.23K | $4.16M | 新进 |
| Q2 2025 | 285.40K | $3.81M | 减持 |
| Q3 2025 | 258.62K | $4.09M | 减持 |
| Q4 2025 | 96.80K | $1.97M | 减持 |
| Q1 2026 | 54.40K | $600.58K | 减持 |
| Q2 2026 | 54.40K | $582.08K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 KROS 与 13F 数据
KROS(KEROS THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 13 只申报持有 KROS,申报仓位最大的包括:Nantahala Capital Management, LLC (US$15.1M), Madison Avenue Partners, LP (US$6.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 KROS 的基金
- Nantahala Capital Management, LLC 1.41M 股 · $15.09M · Q2 2026
- Madison Avenue Partners, LP 626.58K 股 · $6.70M · Q2 2026
更多关于 Rangeley Capital, LLC
常见问题
How long has Rangeley Capital, LLC held KROS?
Rangeley Capital, LLC has disclosed KROS holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Rangeley Capital, LLC's current position in KROS?
As of Q2 2026, Rangeley Capital, LLC holds 54.40K shares of KROS (KEROS THERAPEUTICS INC), valued at $582.08K, representing 0.55% of its reported portfolio and ranking #47.
Has Rangeley Capital, LLC been buying or selling KROS?
In the latest 13F filing (Q2 2026), Rangeley Capital, LLC held unchanged its position in KROS.
Which other funds hold KROS?
Other major institutional holders of KROS include Nantahala Capital Management, LLC, Madison Avenue Partners, LP, among 13 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.